Riviciclib

Cat. No.: IBDI-437065

Riviciclib (P276-00 free base) is a potent cyclin-dependent kinase (CDK) inhibitor, which inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively. Riviciclib shows antitumor activity on cisplatin-resistant cells.

Product Details

Target	CDK
Molecular Weight	401.84
Synonyms	P276-00 free base
SMILES	O=C1C=C(C2=C(Cl)C=CC=C2)OC3=C([[email protected]]4[[email protected]](CO)N(C)CC4)C(O)=CC(O)=C13

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.